Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Bipartisan Group of Senate Health Committee Members Introduce Bill to Spur Development of New Non-Addictive Painkiller


 

WASHINGTON, February 8 -- Senate Health Committee Chairman Lamar Alexander (R-Tenn.), Ranking Member Patty Murray (D-Wash.) and HELP committee members Todd Young (R-Ind.), and Maggie Hassan (D-N.H.), today introduced legislation to advance urgently needed research to address the opioid crisis.

The Advancing Cutting-Edge (ACE) Research Act would provide the National Institutes of Health (NIH) with more flexible authority to conduct innovative research to increase scientific understanding and lead to ways to prevent, treat, diagnose and cure disease, including research that is urgently required to respond to public health threats such as the opioid crisis.

Chairman Lamar Alexander (R-Tenn.) said: "Dr. Collins has predicted that the development of a new, non-addictive painkiller could be achieved within five years with consistent funding and more flexible authority to conduct the necessary research. This legislation builds on the 21st Century Cures Act by giving the NIH even more flexibility to conduct research to address the opioid crisis, for example by entering research contracts more quickly or partnering with innovative companies. I will be working with my fellow co-sponsors to build support for this legislation in the Senate, and I'm hopeful to begin marking up legislation to help address the opioids crisis this spring."

Ranking Member Patty Murray (D-Wash.) said: "We took much-needed steps in the 21st Century Cures Act and Comprehensive Addiction and Recovery Act to ensure that the National Institutes of Health has the tools and direction to support innovative medical research to combat the opioid crisis. We must build on that bipartisan progress by continuing to fight for the resources needed to help implement existing solutions as well as provide additional flexibility to leverage cutting-edge technology to help innovators and researchers develop new ones."

Senator Todd Young (R-Ind.) said: "I'm proud to join my colleagues in introducing The Advancing Cutting-Edge (ACE) Research Act to fight back against the devastating opioid epidemic that is affecting Hoosiers and Americans from all walks of life. This bipartisan legislation will help encourage the innovative research necessary to understanding, treating, and ending our nation's most harmful health threats like the opioid crisis."

Senator Maggie Hassan (D-N.H.) said: "The fentanyl, heroin, and opioid crisis continues to devastate communities across New Hampshire and the country, and we know that it stems in large part from the overprescribing of highly addictive painkillers. Non-addictive pain treatment options could help us turn the tide of this epidemic and help save lives by preventing addiction from taking hold in the first place. The bipartisan Advancing Cutting-Edge Research Act will provide the National Institutes of Health with more flexibility to conduct innovative research on alternatives to traditional opioid painkillers, and I look forward to working with my colleagues across the aisle to move this critical legislation forward."

Background:

  • According to a Centers for Disease Control and Prevention (CDC) report, there were 63,632 drug overdose deaths in the U.S. in 2016, and 42,249 deaths related to opioids overdoses--115 Americans die every day from an opioid overdose.
  • In July 2017, the CDC reported that the amount of opioids prescribed in 2015 was enough for every American to be medicated around the clock for three weeks.
  • CDC's 2017 Annual Surveillance Report of Drug-Related Risks and Outcomes highlights that opioid overdose death rates are largely a result of prescription or illicit opioids, including heroin and illicit fentanyl, a synthetic opioid.
  • Giving the Director of NIH authority to approve projects using other transaction authority for cutting-edge research will allow NIH to partner with innovative companies more quickly to enhance research efforts in response to the opioid crisis and other public health threats. This authority can also be used to support research that increases the fundamental understanding of diseases or disorders and find ways to prevent, treat, and cure them.

Click here for the text of the legislation and here for a one-page summary.

 
Share:

Related Articles:


Recent Articles

Bipartisan Group of Senate Health Committee Members Introduce Bill to Spur Development of New Non-Addictive Painkiller

Read More

There's a New Bipartisan Budget & Most Healthcare Organizations are Happy

Read More

AHA Supportive of Bill Addressing Community Rights to Set Smoking Policy

Preemption Repeal a Breath of Fresh Air for Tennessee: The fate of local smoking ordinances impacting the secondhand smoke Tennesseans breathe may finally be given to communities at the local level. Municipalities throughout Tennessee would be allowed to craft their own local smoking policies protecting the health of citizens through a bill making its way through the Tennessee Legislature.

Read More

Healthcare Collaboration

Key healthcare associations and payer organizations look to simplify the pre-authorization process with a recently released consensus statement outlining key areas for improvement.

Read More

The Battle over 340B

The battle over 340B continues as hospitals serving some of the nation's most vulnerable patients worry what will happen if $1.6 billion in cuts go through.

Read More

Position on Governor Haslam's TN Together Initiative

The Tennessee Medical Association Board of Trustees has adopted the following position on Governor Haslam's TN Together plan for addressing the state's opioid abuse epidemic.

Read More

Doctors Aim for Another Big Year on Capitol Hill

With the 2018 legislative session in full swing, TMA is ready to advocate on behalf of its more than 9,000 physician members.

Read More

DOJ Signals New Approach to Frivolous Qui Tam Actions

The Department of Justice recently signaled a possible move toward dismissing more qui tam cases deemed to be meritless.

Read More

Wall Street Weighs In for 2018

Top Wall Street analysts shared their industry predictions for 2018 at the Nashville Health Care Council signature event.

Read More

The Impact of Clinical Trials in Tennessee

With nearly 1,000 clinical trials in the state, a new study finds biopharma research supports 52,000 jobs in Tennessee and ads $11.7 billion to the economy.

Read More

Email Print
 
 

 

 


Tags:
ACE Act, Advancing Cutting-Edge Research Act, HELP Committee, Lamar Alexander, National Institutes of Health, NIH, Opioid Addiction, Opioid Epidemic, Opioids, Patty Murray
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: